JPH11253193A - Test piece for assaying creatine kinase activity - Google Patents
Test piece for assaying creatine kinase activityInfo
- Publication number
- JPH11253193A JPH11253193A JP35747898A JP35747898A JPH11253193A JP H11253193 A JPH11253193 A JP H11253193A JP 35747898 A JP35747898 A JP 35747898A JP 35747898 A JP35747898 A JP 35747898A JP H11253193 A JPH11253193 A JP H11253193A
- Authority
- JP
- Japan
- Prior art keywords
- test piece
- creatine kinase
- tetrazolium
- diaphorase
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 95
- 102000004420 Creatine Kinase Human genes 0.000 title claims abstract description 55
- 108010042126 Creatine kinase Proteins 0.000 title claims abstract description 55
- 230000000694 effects Effects 0.000 title claims abstract description 43
- 125000003831 tetrazolyl group Chemical group 0.000 claims abstract description 28
- 101710088194 Dehydrogenase Proteins 0.000 claims abstract description 10
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 claims abstract description 8
- -1 polyethylene terephthalate Polymers 0.000 claims abstract description 8
- 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 claims abstract description 4
- 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 claims abstract description 4
- 102000002247 NADPH Dehydrogenase Human genes 0.000 claims abstract 2
- 108010014870 NADPH Dehydrogenase Proteins 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims abstract 2
- QOIRFXTZHVPXLR-UHFFFAOYSA-N 2,3,5-triphenyl-1h-tetrazole Chemical compound N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 QOIRFXTZHVPXLR-UHFFFAOYSA-N 0.000 claims description 3
- DVYSLVUKWUHBQL-UHFFFAOYSA-N 4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-1h-tetrazol-5-yl]benzene-1,3-disulfonic acid Chemical compound COC1=CC([N+]([O-])=O)=CC=C1N1N(C=2C=CC(=CC=2)[N+]([O-])=O)N=C(C=2C(=CC(=CC=2)S(O)(=O)=O)S(O)(=O)=O)N1 DVYSLVUKWUHBQL-UHFFFAOYSA-N 0.000 claims description 3
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 claims description 3
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 2
- BSGLZRUFGPBMAJ-UHFFFAOYSA-N [O-]S(C1=CC(S(O)(=O)=O)=CC=C1[N+]1=CN=NN1)(=O)=O Chemical compound [O-]S(C1=CC(S(O)(=O)=O)=CC=C1[N+]1=CN=NN1)(=O)=O BSGLZRUFGPBMAJ-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 24
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 12
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 abstract description 3
- 239000005020 polyethylene terephthalate Substances 0.000 abstract description 3
- PAJSIAXXSFQVPJ-UHFFFAOYSA-N 4-[2-(4-iodophenyl)-3-(4-nitrophenyl)-1h-tetrazol-5-yl]benzene-1,3-disulfonic acid Chemical compound OS(=O)(=O)C1=CC(S(=O)(=O)O)=CC=C1C1=NN(C=2C=CC(=CC=2)[N+]([O-])=O)N(C=2C=CC(I)=CC=2)N1 PAJSIAXXSFQVPJ-UHFFFAOYSA-N 0.000 abstract description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 2
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 229920001577 copolymer Polymers 0.000 abstract description 2
- 238000007605 air drying Methods 0.000 abstract 1
- WUJUYHMGDPTLMG-UHFFFAOYSA-N imidazol-2-ylacetic acid Chemical compound OC(=O)CC1=NC=CN1 WUJUYHMGDPTLMG-UHFFFAOYSA-N 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 22
- 108090000790 Enzymes Proteins 0.000 description 22
- 239000000047 product Substances 0.000 description 21
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 20
- JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 18
- 239000003153 chemical reaction reagent Substances 0.000 description 17
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 17
- 238000005259 measurement Methods 0.000 description 16
- 239000000758 substrate Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 11
- VSIVTUIKYVGDCX-UHFFFAOYSA-M sodium;4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].COC1=CC([N+]([O-])=O)=CC=C1[N+]1=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=NN1C1=CC=C([N+]([O-])=O)C=C1 VSIVTUIKYVGDCX-UHFFFAOYSA-M 0.000 description 11
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 6
- 239000012190 activator Substances 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 5
- 229960004308 acetylcysteine Drugs 0.000 description 5
- 238000004040 coloring Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical class CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 4
- OFGDSGVGRWPQJQ-UHFFFAOYSA-N 1h-imidazol-1-ium;acetate Chemical compound CC(O)=O.C1=CNC=N1 OFGDSGVGRWPQJQ-UHFFFAOYSA-N 0.000 description 4
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 4
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 102000030595 Glucokinase Human genes 0.000 description 4
- 108010021582 Glucokinase Proteins 0.000 description 4
- 239000008351 acetate buffer Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 102000010705 glucose-6-phosphate dehydrogenase activity proteins Human genes 0.000 description 4
- 108040005050 glucose-6-phosphate dehydrogenase activity proteins Proteins 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 241000193403 Clostridium Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000005548 Hexokinase Human genes 0.000 description 3
- 108700040460 Hexokinases Proteins 0.000 description 3
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 3
- 229940069446 magnesium acetate Drugs 0.000 description 3
- 235000011285 magnesium acetate Nutrition 0.000 description 3
- 239000011654 magnesium acetate Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- MUUHXGOJWVMBDY-UHFFFAOYSA-L tetrazolium blue Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 MUUHXGOJWVMBDY-UHFFFAOYSA-L 0.000 description 3
- RONADMZTCCPLEF-UHFFFAOYSA-M tetrazolium violet Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C3=CC=CC=C3C=CC=2)=NN1C1=CC=CC=C1 RONADMZTCCPLEF-UHFFFAOYSA-M 0.000 description 3
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- WYFYSTBFFDOVJW-UHFFFAOYSA-L 2-[4-[4-(3,5-diphenyltetrazol-2-ium-2-yl)phenyl]phenyl]-3,5-diphenyltetrazol-2-ium;dichloride Chemical compound [Cl-].[Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC(=CC=2)C=2C=CC(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=NN1C1=CC=CC=C1 WYFYSTBFFDOVJW-UHFFFAOYSA-L 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 1
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 description 1
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 1
- GXVUZYLYWKWJIM-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanamine Chemical compound NCCOCCN GXVUZYLYWKWJIM-UHFFFAOYSA-N 0.000 description 1
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 1
- POVFIALPFNAYPM-UHFFFAOYSA-N 2-naphthalen-1-yl-3,5-diphenyl-1h-tetrazole Chemical compound N1N(C=2C3=CC=CC=C3C=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 POVFIALPFNAYPM-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 102000002794 Glucosephosphate Dehydrogenase Human genes 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 101000641031 Homo sapiens Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- FBWADIKARMIWNM-UHFFFAOYSA-N N-3,5-dichloro-4-hydroxyphenyl-1,4-benzoquinone imine Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1N=C1C=CC(=O)C=C1 FBWADIKARMIWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920006361 Polyflon Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000588901 Zymomonas Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- XAZMYOQLNVTRPS-UHFFFAOYSA-L disodium;2-[[4-[2-(1,3-benzothiazol-2-yl)-3-[4-[4-[3-(1,3-benzothiazol-2-yl)-5-[4-[bis(2-sulfonatoethyl)carbamoyl]phenyl]tetrazol-3-ium-2-yl]-3-methoxyphenyl]-2-methoxyphenyl]tetrazol-2-ium-5-yl]benzoyl]-(2-sulfonatoethyl)amino]ethanesulfonate Chemical compound [Na+].[Na+].COC1=CC(C=2C=C(OC)C(=CC=2)N2[N+](=NC(=N2)C=2C=CC(=CC=2)C(=O)N(CCS([O-])(=O)=O)CCS([O-])(=O)=O)C=2SC3=CC=CC=C3N=2)=CC=C1N([N+](=N1)C=2SC3=CC=CC=C3N=2)N=C1C1=CC=C(C(=O)N(CCS([O-])(=O)=O)CCS([O-])(=O)=O)C=C1 XAZMYOQLNVTRPS-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、試料中のクレアチ
ンキナーゼ活性を測定するための試験片に関するもので
ある。TECHNICAL FIELD The present invention relates to a test strip for measuring creatine kinase activity in a sample.
【0002】[0002]
【従来の技術】近年、病態の検査、診断を行うための試
薬として、従来から用いられている有機化学試薬に代わ
って、酵素反応を利用した試薬が広く利用されている。
酵素反応を利用した試薬は、酵素が生体中の特定の成分
を特異的に検出可能物質に変換する性質を利用したもの
であり、通常、測定しようとする測定対象物質(A)
を、これに特異的な酵素(a)を用いて中間生成物(I
−1)に変換し、さらにこの中間生成物(I−1)に特
異的な酵素(i−1)を作用させて中間生成物(I−
2)に変換するという反応を繰り返して、最終的に検出
可能物質(F)に変換し、この検出可能物質(F)を分
光光度計などを用いて又は肉眼等による色調の変化から
定量するものである。2. Description of the Related Art In recent years, reagents utilizing an enzymatic reaction have been widely used as reagents for examining and diagnosing disease states, instead of conventionally used organic chemical reagents.
A reagent utilizing an enzyme reaction utilizes the property of an enzyme to specifically convert a specific component in a living body into a detectable substance, and is usually a substance to be measured (A)
Is converted to an intermediate product (I) using an enzyme (a) specific thereto.
-1). The intermediate (I-1) is further reacted with a specific enzyme (i-1) to react with the intermediate (I-1).
2) The reaction of conversion to 2) is repeated and finally converted to a detectable substance (F), and this detectable substance (F) is quantified using a spectrophotometer or the like, or from a change in color tone due to the naked eye or the like. It is.
【0003】[0003]
【化1】 Embedded image
【0004】このような試薬において、検出可能物質
(F)としては、NADやその還元型(NADH)及び
これらの類縁化合物であるNADPやその還元型(NA
DPH)等が広く利用されており(以下、これらの化合
物を総称する場合、ニコチンヌクレオチド類と称す
る)、これらのニコチンヌクレオチド類は紫外部(34
0nm付近)で吸光度の変化が認められることから、生
成又は減少したニコチンヌクレオチド類を分光器を用い
て測定する試薬が提案されている。また、生成したNA
DH又はNADPHにジアホラーゼを作用させること
で、テトラゾリウムをホルマザンに変換させて可視領域
で測定する試薬も数多く報告されている〔例えば、胆汁
酸(特開昭60−214900号公報、臨床化学第19
巻、290〜299頁(1990))、トリグリセリド
(特開昭55−14899号公報)、アルコール(特公
平4−3947号公報)、アミラーゼ(特公昭63−3
7640号公報)、クレアチンキナーゼ(特開昭58−
16699号公報)、NAD(P)H(特公平4−70
000号公報)、ポリアミン(特公平6−68490号
公報)、グルコース(特公平7−34757号公報)、
ベンジルアミン(特開平7−184693号公報)〕。
また、クレアチンキナーゼ活性測定用の試験片について
も報告されている(特開昭63−283600号公報、
特公平6−95959号公報、特開平1−320999
号公報)。In such reagents, the detectable substance (F) includes NAD and its reduced form (NADH), and their analogous compounds NADP and its reduced form (NAD).
DPH) and the like are widely used (hereinafter, these compounds are collectively referred to as nicotine nucleotides), and these nicotine nucleotides are ultraviolet (34)
Since a change in absorbance is observed at around 0 nm), a reagent for measuring the generated or reduced nicotine nucleotides using a spectrometer has been proposed. Also, the generated NA
Many reagents have been reported which convert tetrazolium to formazan by measuring DH or NADPH with diaphorase to measure in the visible region [for example, bile acids (JP-A-60-214900, Clinical Chemistry No. 19).
Volume, pp. 290-299 (1990)), triglycerides (JP-A-55-14899), alcohols (JP-B-4-3947), and amylase (JP-B-63-3).
No. 7640), creatine kinase (Japanese Unexamined Patent Application Publication No.
No. 16699), NAD (P) H (Japanese Patent Publication No. 4-70)
000), polyamines (Japanese Patent Publication No. 6-68490), glucose (Japanese Patent Publication No. 7-34757),
Benzylamine (JP-A-7-184693)].
Also, a test piece for measuring creatine kinase activity has been reported (Japanese Patent Application Laid-Open No. 63-283600,
JP-B-6-95959, JP-A-1-320999
No.).
【0005】しかし、これらの試薬には、発色試薬とし
てジクロロフェノールインドフェノール(以下、DCI
Pと略す。)や、テトラゾリウムブルー、ネオテトラゾ
リウムブルー、MTT、INT、ニトロテトラゾリウム
ブルーを用いている。上記発色試薬のうちDCIPはジ
アホラーゼの作用で着色した状態から無色の状態となる
ため、試験片の作製には不適当である。また、その他の
発色試薬として用いられているテトラゾリウムは水に対
する溶解性が低いため、試験片の作成が容易ではなく
(比較例参照)、さらに、試験片の形に加工した場合で
も、十分な測定域を得ることができず、このため測定す
る試料を希釈する等の操作が必要であった(例えば、メ
ディカルテクノロジー誌、11巻、6号、496〜50
5頁には、クレアチンキナーゼ活性を測定する場合、試
料を9倍に希釈しても1000ユニット/lまでしか活
性を測定できないことが記載されている。)。また、こ
れらの試験片では、被検体である血液や尿等が水性であ
るため、被検体を試験片に直接添加して反射光を測定し
ても、高感度かつ再現性よく活性を測定することが極め
て困難であるという問題点があった。However, these reagents include dichlorophenol indophenol (hereinafter referred to as DCI) as a coloring reagent.
Abbreviated as P. ), Tetrazolium blue, neotetrazolium blue, MTT, INT, and nitrotetrazolium blue. Among the above color forming reagents, DCIP changes from a colored state due to the action of diaphorase to a colorless state, and thus is not suitable for preparing test pieces. In addition, tetrazolium, which is used as another color-forming reagent, has low solubility in water, so it is not easy to prepare a test piece (see Comparative Example). Therefore, an operation such as diluting the sample to be measured was required (for example, Medical Technology Magazine, Vol. 11, No. 6, 496-50).
On page 5, it is described that when measuring creatine kinase activity, the activity can be measured only up to 1000 units / l even if the sample is diluted 9-fold. ). In these test strips, since the blood, urine, and the like, which are the test specimens, are aqueous, even if the test specimens are directly added to the test specimens and the reflected light is measured, the activity is measured with high sensitivity and reproducibility. There was a problem that it was extremely difficult.
【0006】一方、クレアチンキナーゼのような酵素以
外の例では、無機物であるマグネシウムの測定用試験片
に還元系発色剤を用いた例があり、還元系発色剤の例と
してテトラゾリウム塩を挙げているものがあるが(例え
ば、特開平9−266796号公報、特開平9−266
797号公報)、例示されているテトラゾリウム塩とし
てはテトラゾリウムバイオレットのみが水溶性の高いテ
トラゾリウム塩であり、他はいずれも水に対する溶解性
が低いものである。また、この試験片では他の代表的な
水溶性テトラゾリウムを発色剤として用いた場合、自発
的な着色がおこることから、試験片に発色試薬として水
溶性テトラゾリウムを使用するのは不適当であるものと
考えられた。On the other hand, in examples other than enzymes such as creatine kinase, there is an example in which a reducing color former is used for a test piece for measuring magnesium, which is an inorganic substance, and a tetrazolium salt is mentioned as an example of the reducing color former. There are some (for example, JP-A-9-266796, JP-A-9-266).
797), only tetrazolium violet is a highly water-soluble tetrazolium salt among the exemplified tetrazolium salts, and all others have low solubility in water. In addition, when other representative water-soluble tetrazolium is used as a coloring agent in this test piece, spontaneous coloring occurs, so it is inappropriate to use water-soluble tetrazolium as a coloring reagent in the test piece. It was considered.
【0007】本発明は、反射光を測定することで、広範
囲の測定領域で高感度にクレアチンキナーゼ活性を測定
することのできる試験片を提供することを目的とするも
のである。[0007] It is an object of the present invention to provide a test strip capable of measuring creatine kinase activity with high sensitivity over a wide measurement area by measuring reflected light.
【0008】[0008]
【課題を解決するための手段】本発明者らは、上記課題
を解決するために鋭意検討の結果、試験片には不適当と
考えられた水溶性テトラゾリウムを用いたクレアチンキ
ナーゼ活性測定用試験片を作製することができ、さら
に、該試験片は水溶性テトラゾリウムを用いることによ
り、広範囲の測定領域で高感度で、クレアチンキナーゼ
活性を測定することができるということを見い出し、本
発明に到達した。すなわち、第1の発明は、少なくと
も、デヒドロゲナーゼ、ジアホラーゼ、NAD又はNA
DP、水溶性テトラゾリウム及び担体からなることを特
徴とするクレアチンキナーゼ活性測定用試験片を要旨と
するものである。また、第2の発明は、水溶性テトラゾ
リウムが2−(4−ヨードフェニル)−3−(4−ニト
ロフェニル)−5−(2,4−ジスルホフェニル)−2
H−テトラゾリウム、2−(4−ニトロ,2−メトキシ
フェニル)−3−(4−ニトロフェニル)−5−(2,
4−ジスルホフェニル)−2H−テトラゾリウム、2,
3,5−トリフェニル−2H−テトラゾリウム又は2,
5−ジフェニル−3−(1−ナフチル)−2H−テトラ
ゾリウムである上記の試験片を要旨とするものである。Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that a test piece for measuring creatine kinase activity using a water-soluble tetrazolium which is considered to be inappropriate. Was further found to be able to measure creatine kinase activity with high sensitivity over a wide measurement range by using water-soluble tetrazolium, and reached the present invention. That is, the first invention includes at least dehydrogenase, diaphorase, NAD or NA.
A gist of a test strip for measuring creatine kinase activity, comprising a DP, a water-soluble tetrazolium, and a carrier. In the second invention, the water-soluble tetrazolium is 2- (4-iodophenyl) -3- (4-nitrophenyl) -5- (2,4-disulfophenyl) -2.
H-tetrazolium, 2- (4-nitro, 2-methoxyphenyl) -3- (4-nitrophenyl) -5- (2,
4-disulfophenyl) -2H-tetrazolium, 2,
3,5-triphenyl-2H-tetrazolium or 2,
The gist of the test piece is 5-diphenyl-3- (1-naphthyl) -2H-tetrazolium.
【0009】[0009]
【発明の実施の形態】以下、本発明を詳細に説明する。
本発明に用いられるデヒドロゲナーゼとしては、グルコ
ース6−リン酸に特異的に作用するデヒドロゲナーゼで
あれば特に限定はなく、例えば、グルコース6−リン酸
デヒドロゲナーゼが挙げられる。その供給源となる生物
種等は特に限定されるものではなく、例えば、乳酸菌や
ザイモモナス属等の微生物由来のもの等が挙げられる。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail.
The dehydrogenase used in the present invention is not particularly limited as long as it is a dehydrogenase that specifically acts on glucose 6-phosphate, and examples include glucose 6-phosphate dehydrogenase. There are no particular limitations on the species of the organism as the source, and examples thereof include those derived from microorganisms such as lactic acid bacteria and Zymomonas.
【0010】本発明に用いられる水溶性テトラゾリウム
としては、水に対する溶解度が5mM以上であり、かつ
NADH又はNADPHの存在下、ジアホラーゼの作用
により、還元されて発色するものであれば特に限定され
るものではなく、例えば、2−(4−ヨードフェニル)
−3−(4−ニトロフェニル)−5−(2,4−ジスル
ホフェニル)−2H−テトラゾリウム、2−(4−ニト
ロ,2−メトキシフェニル)−3−(4−ニトロフェニ
ル)−5−(2,4−ジスルホフェニル)−2H−テト
ラゾリウム、2,3,5−トリフェニル−2H−テトラ
ゾリウム又は2,5−ジフェニル−3−(1−ナフチ
ル)−2H−テトラゾリウム、2−(4−ヨードフェニ
ル)−3−(2,4−ジニトロフェニル)−5−(2,
4−ジスルホフェニル−2H−テトラゾリウム、2−
(2−メトキシ,4−カルボキシフェニル)−3−ベン
ゾチアジル−5−(4−スルフォエチルアミノカルボニ
ルフェニル)−2H−テトラゾリウム、3,3’−
[3,3’−ジメトキシ−(1,1’−ビフェニル)−
4,4’−ジイル]−ビス[2−ベンゾチアジル−4−
(4−ジスルフォエチルアミノカルボニルフェニル)−
テトラゾリウム]等が挙げられる。これらの水溶性テト
ラゾリウムは、それぞれWST−1、WST−8、テト
ラゾリウム・レッド(以下、TRと略す。)、テトラゾ
リウム・バイオレット(以下、TVと略す。)、WST
−3、WST−4、WST−5という商品名で、同人化
学研究所又はシグマ・アルドリッチ社から市販もしくは
サンプル供給されている。これらの水溶性テトラゾリウ
ムの中でもWST−1、WST−8、TR、TVは試験
片に均一に固定することができるので好ましい。また、
WST−1、WST−8、TRは溶液や溶媒に容易に溶
解し、さらに、試験片上に十分な量保持させることがで
きるので特に好ましい。以下に、WST−1、WST−
8、TR、TVの構造式を示す。[0010] The water-soluble tetrazolium used in the present invention is not particularly limited as long as it has a solubility in water of 5 mM or more and is colored by being reduced by the action of diaphorase in the presence of NADH or NADPH. Instead, for example, 2- (4-iodophenyl)
-3- (4-Nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium, 2- (4-nitro, 2-methoxyphenyl) -3- (4-nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium, 2,3,5-triphenyl-2H-tetrazolium or 2,5-diphenyl-3- (1-naphthyl) -2H-tetrazolium, 2- (4- Iodophenyl) -3- (2,4-dinitrophenyl) -5- (2
4-disulfophenyl-2H-tetrazolium, 2-
(2-methoxy, 4-carboxyphenyl) -3-benzothiazyl-5- (4-sulfoethylaminocarbonylphenyl) -2H-tetrazolium, 3,3′-
[3,3'-Dimethoxy- (1,1'-biphenyl)-
4,4′-diyl] -bis [2-benzothiazyl-4-
(4-disulfoethylaminocarbonylphenyl)-
Tetrazolium]. These water-soluble tetrazoliums are WST-1, WST-8, tetrazolium red (hereinafter abbreviated as TR), tetrazolium violet (hereinafter abbreviated as TV), and WST, respectively.
-3, WST-4, and WST-5, and are commercially available or supplied as samples from Dojindo Chemical Laboratories or Sigma-Aldrich. Among these water-soluble tetrazoliums, WST-1, WST-8, TR, and TV are preferable because they can be uniformly fixed to a test piece. Also,
WST-1, WST-8, and TR are particularly preferable because they can be easily dissolved in a solution or a solvent and can be retained on a test piece in a sufficient amount. Below, WST-1, WST-
8, the structural formulas of TR and TV are shown.
【0011】[0011]
【化2】 Embedded image
【0012】[0012]
【化3】 Embedded image
【0013】[0013]
【化4】 Embedded image
【0014】[0014]
【化5】 Embedded image
【0015】本発明に用いられるにジアホラーゼとして
は、上述の反応を触媒するものであれば、その供給源と
なる生物種等は特に限定されるものではなく、例えば、
バチルス・ステアロサーモフィルス、クロストリジウム
・クルイベリ等の微生物由来のものや、ブタ心臓由来の
もの等が挙げられる。なかでも、好熱性微生物由来のジ
アホラーゼは保存安定性に優れていることから好まし
く、具体的には、バチルス・ステアロサーモフィルス由
来のジアホラーゼを用いることが好ましい。The diaphorase used in the present invention is not particularly limited as long as it catalyzes the above-mentioned reaction, and the source species thereof is not particularly limited.
Examples thereof include those derived from microorganisms such as Bacillus stearothermophilus and Clostridium kluyberg and those derived from pig heart. Among them, diaphorase derived from a thermophilic microorganism is preferable because of its excellent storage stability, and specifically, diaphorase derived from Bacillus stearothermophilus is preferably used.
【0016】また、本発明に用いられるジアホラーゼと
しては、クレアチンキナーゼ活性測定の精度を向上させ
るために、下式で算出されるテトラゾリウムと還元型ニ
コチンヌクレオチド(NADH又はNADPH)からホ
ルマザンと酸化型ニコチンヌクレオチド(NAD又はN
ADP)への方向の反応平衡定数(K値)が1以上、好
ましくは10以上、さらに好ましくは100以上のもの
を用いることが好ましく、例えば、バチルス・ステアロ
サーモフィルス由来のジアホラーゼI又はジアホラーゼ
IIを用いることが好ましい。The diaphorase used in the present invention includes formazan and oxidized nicotine nucleotide from tetrazolium and reduced nicotine nucleotide (NADH or NADPH) calculated by the following formula in order to improve the accuracy of creatine kinase activity measurement. (NAD or N
It is preferable to use one having a reaction equilibrium constant (K value) of 1 or more, preferably 10 or more, more preferably 100 or more in the direction toward ADP). For example, diaphorase I or diaphorase derived from Bacillus stearothermophilus
Preferably, II is used.
【0017】[0017]
【化6】 Embedded image
【0018】これらの成分は、クレアチンキナーゼの関
与する反応からホルマザンへの酵素反応が70%以上、
好ましくは90%以上、さらに好ましくは95%以上進
行するように配合することが好ましく、ジアホラーゼと
しては、0.1〜100万ユニット/l、好ましくは
0.1〜1万ユニット/l、さらに好ましくは1〜10
00ユニット/lの濃度の酵素液を試験片100cm2
当り0.1〜1万μl、好ましくは1〜1000μl、
さらに好ましくは1〜100μl含有させればよい。ま
た、デヒドロゲナーゼとしては、ジアホラーゼの濃度と
同じ程度でよい。NAD又はNADPとしては、0.0
01nM〜200mM、さらに好ましくは0.1nM〜
50mMの溶液を、試験片100cm2 当り0.1〜1
万μl、好ましくは1〜1000μl、さらに好ましく
は1〜100μl含有させればよい。[0018] These components have an enzymatic reaction to formazan of 70% or more from a reaction involving creatine kinase,
The diaphorase is preferably blended so as to progress preferably at least 90%, more preferably at least 95%, and as diaphorase, it is preferably 0.1 to 1,000,000 units / l, more preferably 0.1 to 10,000 units / l. Is 1 to 10
An enzyme solution having a concentration of 00 units / l was applied to a test piece 100 cm 2
0.1 to 10,000 μl, preferably 1 to 1000 μl,
More preferably, it may be contained in an amount of 1 to 100 μl. The dehydrogenase may be at the same level as the concentration of diaphorase. As NAD or NADP, 0.0
01 nM to 200 mM, more preferably 0.1 nM to
A 50 mM solution was applied at 0.1 to 1 per 100 cm 2 of the test piece.
It may be contained in an amount of 10,000 μl, preferably 1 to 1000 μl, more preferably 1 to 100 μl.
【0019】水溶性テトラゾリウムの量としては、試験
片100cm2 当り0.01〜500mg、好ましくは
0.1〜100mg、さらに好ましくは0.1〜50m
g含有させればよい。このとき、水溶性テトラゾリウム
の量が少なすぎると発色が低くなり、過剰であると不溶
性となって精度低下をきたすことがあるので好ましくな
い。The amount of the water-soluble tetrazolium is 0.01 to 500 mg, preferably 0.1 to 100 mg, more preferably 0.1 to 50 mg per 100 cm 2 of the test piece.
g may be contained. At this time, if the amount of the water-soluble tetrazolium is too small, the coloring becomes low, and if it is excessive, it becomes insoluble and the accuracy may be lowered, which is not preferable.
【0020】具体的に、クレアチンキナーゼ活性を測定
する場合には、例えば以下の反応式(1)に従ってクレ
アチンキナーゼ活性が測定できるように酵素類や基質類
を含有させればよい。Specifically, when measuring creatine kinase activity, enzymes and substrates may be contained so that creatine kinase activity can be measured, for example, according to the following reaction formula (1).
【0021】[0021]
【化7】 Embedded image
【0022】本発明の試験片は、少なくとも、酵素類と
してはデヒドロゲナーゼ、ジアホラーゼ、基質類として
はNAD又はNADP、水溶性テトラゾリウムを含むも
のであるので、他の酵素類であるヘキソキナーゼ又はグ
ルコキナーゼや、他の基質類であるクレアチンリン酸、
グルコース、ADPは必要に応じて含めさせればよい。
また、上記酵素類、基質類以外のものとして、必要に応
じて、アスコルビン酸オキシダーゼ、N−アセチルシス
テイン、マグネシウムイオン等を共存させてもよい。Since the test strip of the present invention contains at least dehydrogenase and diaphorase as enzymes and NAD or NADP as substrates and water-soluble tetrazolium, other enzymes such as hexokinase or glucokinase, Creatine phosphate which is a substrate,
Glucose and ADP may be included as needed.
In addition, ascorbic acid oxidase, N-acetylcysteine, magnesium ion and the like may be coexisted as necessary other than the above enzymes and substrates.
【0023】本発明の試験片に上記の酵素類、基質類等
を含める場合、試験片を構成する担体に必要な酵素類、
基質類等をすべて含浸させればよい。含浸させる際、試
験片を構成する担体の同じ部分にすべての必要な酵素
類、基質類等を含浸させてもよく、また、必要な酵素
類、基質類等のうちの一部を試験片を構成する担体の一
部分に含浸させ、残りの必要な酵素類、基質類等を試験
片を構成する担体の他の部分に分けて含浸させてもよ
い。When the test strip of the present invention contains the above enzymes, substrates, etc., the enzymes necessary for the carrier constituting the test strip,
What is necessary is just to impregnate all the substrates and the like. When impregnating, the same part of the carrier constituting the test piece may be impregnated with all necessary enzymes, substrates, etc., and a part of the necessary enzymes, substrates, etc. A part of the carrier constituting the test piece may be impregnated, and the remaining necessary enzymes, substrates and the like may be separately impregnated into the other part of the carrier constituting the test piece.
【0024】上記の酵素類、基質類等のうち、保存時の
安定性の点からN−アセチルシステインと水溶性テトラ
ゾリウムとは試験片を構成する担体の異なる部分に含浸
させる方が好ましい場合がある。また、デヒドロゲナー
ゼとしてグルコース−6−リン酸デヒドロゲナーゼを用
いる際、同様の理由でグルコースとグルコース−6−リ
ン酸デヒドロゲナーゼとは担体の異なる部分に含浸させ
る方が好ましい場合がある。さらに、マグネシウムイオ
ンとデヒドロゲナーゼ、NADとクレアチンリン酸も同
様の理由でそれぞれ担体の異なる部分に含浸させる方が
好ましい場合がある。Of the above enzymes, substrates and the like, it is sometimes preferable to impregnate N-acetylcysteine and water-soluble tetrazolium into different parts of the carrier constituting the test piece from the viewpoint of stability during storage. . When glucose-6-phosphate dehydrogenase is used as the dehydrogenase, it may be preferable to impregnate glucose and glucose-6-phosphate dehydrogenase in different parts of the carrier for the same reason. Furthermore, it may be preferable to impregnate magnesium ion and dehydrogenase, NAD and creatine phosphate in different parts of the carrier for the same reason.
【0025】この場合、試験片に共存させる各酵素の濃
度としては、ジアホラーゼの濃度と同じ範囲でよい。ま
た、NAD又はNADPやADP等の基質類の濃度とし
ては、0.1〜100mM、好ましくは0.1〜20m
Mの範囲の溶液を、試験片100cm2 当り0.1〜1
万μl、好ましくは1〜1000μl、さらに好ましく
は1〜100μl含有させればよい。In this case, the concentration of each enzyme coexisting on the test piece may be in the same range as the concentration of diaphorase. The concentration of a substrate such as NAD or NADP or ADP is 0.1 to 100 mM, preferably 0.1 to 20 mM.
M range from 0.1 to 1 per 100 cm 2 of test specimen.
It may be contained in an amount of 10,000 μl, preferably 1 to 1000 μl, more preferably 1 to 100 μl.
【0026】本発明においては、pHを調整するための
緩衝剤、活性化剤、安定化剤、増粘剤その他添加剤を試
験片に含有させてもよい。緩衝剤としては、リン酸カリ
ウム、イミダゾール等が挙げられ、項目によっては、2
−モルホリンエタンスルホン酸(MES)、N,N−ビ
ス−(2−ヒドロキシエチル)−2−アミノエタンスル
ホン酸(BES)等のグッド緩衝液が挙げられる。In the present invention, the test piece may contain a buffer, an activator, a stabilizer, a thickener and other additives for adjusting the pH. Examples of the buffer include potassium phosphate, imidazole and the like.
-A good buffer such as morpholineethanesulfonic acid (MES), N, N-bis- (2-hydroxyethyl) -2-aminoethanesulfonic acid (BES).
【0027】活性化剤としては、例えばトリトンX−1
00、ツイン20等のノニオン系又はアニオン系、カチ
オン系の界面活性剤が用いられる。このような活性化剤
は、試験片の保存安定性やブランク値の低下に寄与す
る。これらの活性化剤の濃度としては、0.001〜2
0%、好ましくは0.01〜5%の溶液を、試験片10
0cm2 当り0.1〜1万μl、好ましくは1〜100
0μl、さらに好ましくは1〜100μl含有させれば
よい。As the activator, for example, Triton X-1
Nonionic, anionic or cationic surfactants such as 00 and Twin 20 are used. Such an activator contributes to the storage stability and the blank value of the test piece. The concentration of these activators is 0.001-2.
0%, preferably 0.01-5% solution,
0.1-10000 μl per 0 cm 2 , preferably 1-100
0 μl, more preferably 1 to 100 μl, may be contained.
【0028】また、安定化剤としては、例えばウシ血清
アルブミン等のタンパク質やマルトース、グルコース、
スクロース等の糖類、ポリエチレングリコール等の高分
子化合物、マグネシウム、カリウム、カルシウム等の金
属イオンが用いられる。また金属イオンは酵素の活性化
剤としても働く。さらに、エチレンジアミン四酢酸(E
DTA)、エチレングリコール(β−アミノエチルエー
テル)四酢酸(EGTA)等を用いることもできる。こ
れらの安定化剤の濃度としては、糖は0.1〜50重量
%、好ましくは1〜25重量%の範囲、タンパク質は
0.001〜50重量%、好ましくは0.1〜25重量
%の範囲、金属イオンは0.001〜10mM、好まし
くは0.1〜10mMの範囲、EDTAやEGTAは
0.001〜10mM、好ましくは0.1〜2mMの範
囲の溶液を、試験片100cm2 当り0.1〜1万μ
l、好ましくは1〜1000μl、さらに好ましくは1
〜100μl含有させればよい。Examples of the stabilizer include proteins such as bovine serum albumin, maltose, glucose, and the like.
Saccharides such as sucrose, high molecular compounds such as polyethylene glycol, and metal ions such as magnesium, potassium, and calcium are used. Metal ions also act as activators for enzymes. Further, ethylenediaminetetraacetic acid (E
DTA), ethylene glycol (β-aminoethyl ether) tetraacetic acid (EGTA) and the like can also be used. As to the concentration of these stabilizers, sugar is in the range of 0.1 to 50% by weight, preferably 1 to 25% by weight, and protein is in the range of 0.001 to 50% by weight, preferably 0.1 to 25% by weight. range, metal ions 0.001~10MM, preferably in the range of 0.1-10 mM, EDTA and EGTA are 0.001~10MM, preferably a solution in the range of 0.1 to 2 mm, the test piece 100 cm 2 per 0 .1 to 10,000 μ
1, preferably 1 to 1000 μl, more preferably 1
100100 μl may be contained.
【0029】本発明の試験片に上記の活性化剤、安定化
剤等の添加剤を含有させる場合、必要な酵素類、基質類
等と共に添加剤を、試験片を構成する担体に含浸させれ
ばよい。含浸させる際、すべての必要な酵素類、基質
類、添加剤等を、試験片を構成する担体の同じ部分に含
浸させてもよく、また、必要な酵素類、基質類、添加剤
等のうちの一部を試験片を構成する担体の一部分に含浸
させ、残りの必要な酵素類、基質類、添加剤等を試験片
を構成する担体の他の部分に分けて含浸させてもよい。When the test piece of the present invention contains additives such as the above-mentioned activator and stabilizer, the additives together with necessary enzymes and substrates are impregnated into a carrier constituting the test piece. I just need. When impregnating, all necessary enzymes, substrates, additives, etc. may be impregnated into the same part of the carrier constituting the test piece, and among the necessary enzymes, substrates, additives, etc. May be impregnated into a part of the carrier constituting the test piece, and the remaining necessary enzymes, substrates, additives and the like may be separately impregnated into the other part of the carrier constituting the test piece.
【0030】また、本発明の試験片にEDTAを含有さ
せる際、他にクレアチンリン酸又はN−アセチルシステ
インも含有させるのであれば、保存時の安定性の点か
ら、EDTAとクレアチンリン酸又はN−アセチルシス
テインとは試験片を構成する担体の異なる部分に含浸さ
せる方が好ましい場合がある。When EDTA is added to the test piece of the present invention, if creatine phosphate or N-acetylcysteine is additionally contained, EDTA and creatine phosphate or N-acetylcysteine are added from the viewpoint of storage stability. In some cases, it is preferable to impregnate acetylcysteine into different portions of the carrier constituting the test piece.
【0031】本発明の試験片に用いられる担体として
は、高分子素材からなる公知の担体を用いることがで
き、具体的には、天然繊維や合成繊維からなる抄紙や不
織布、メンブレンフィルター等が挙げられる。メンブレ
ンフィルターとしては、孔径が0.1〜0.5ミクロン
程度のニトロセルロース系の膜、酢酸セルロース系の膜
やポリビニルアルコール系の膜等が挙げられる。As the carrier used for the test piece of the present invention, a known carrier composed of a polymer material can be used, and specific examples include papermaking and nonwoven fabrics composed of natural fibers and synthetic fibers, and membrane filters. Can be Examples of the membrane filter include a nitrocellulose-based membrane having a pore size of about 0.1 to 0.5 μm, a cellulose acetate-based membrane, a polyvinyl alcohol-based membrane, and the like.
【0032】本発明の試験片は、例えば、次のようにし
て作製すればよい。すなわち、上記の成分を水や緩衝液
等に溶解して担体に含浸させた後、凍結乾燥等によって
担体の水分を十分に除くことにより作製することができ
る。The test piece of the present invention may be prepared, for example, as follows. That is, it can be produced by dissolving the above components in water, a buffer solution or the like, impregnating the carrier, and then sufficiently removing the water content of the carrier by freeze-drying or the like.
【0033】このようにして作製した試験片は、小片に
カットして用いることもできるし、また、別の担体上に
貼付してカセットのような形状にして用いることもでき
る。さらに、パッド上に加工することも可能である。The test piece prepared in this manner can be used after being cut into small pieces, or it can be pasted on another carrier and used as a cassette. Furthermore, it is also possible to work on a pad.
【0034】本発明の試験片の被検体は、特に限定され
るものではない。生体成分中のクレアチンキナーゼ活性
を測定する際には、検体として血液、血漿、血清、尿等
の生体試料を用いればよい。The subject of the test strip of the present invention is not particularly limited. When measuring creatine kinase activity in a biological component, a biological sample such as blood, plasma, serum, or urine may be used as a specimen.
【0035】本発明の試験片を用いて生体成分中のクレ
アチンキナーゼ活性を測定するには、例えば以下のよう
にして行うことができる。すなわち、(1)測定対象物
質を含む検体の一定量を試験片上へ滴下する。(2)検
体滴下から一定時間経過した後、十分に検体が試験片に
染み込むことを確認し、適当な反射光測定装置を用い
て、一定の波長の光を照射し、反射強度を測定する。
(3)標準となる量の測定対象物質を同様に測定して検
量線を作成し、この検量線から検体中の測定対象物質の
濃度を算出する。Measurement of creatine kinase activity in a biological component using the test strip of the present invention can be performed, for example, as follows. That is, (1) a fixed amount of the specimen containing the substance to be measured is dropped on the test piece. (2) After a certain period of time has elapsed from the dropping of the sample, it is confirmed that the sample has sufficiently permeated the test piece, and light of a certain wavelength is irradiated using an appropriate reflected light measuring device to measure the reflection intensity.
(3) A standard curve is prepared in the same manner by measuring a standard amount of the measurement target substance, and the concentration of the measurement target substance in the sample is calculated from the calibration curve.
【0036】[0036]
【実施例】次に、本発明を実施例によって具体的に説明
する。本発明で使用したバチルス・ステアロサーモフィ
ルス由来のジアホラーゼI(製品番号100436)、
II(製品番号100437)及びグルコキナーゼ(製
品番号120387)は生化学工業社より購入した。ク
ロストリジウム・クルイベリ由来のジアホラーゼ(製品
番号D5540)及びブタ心臓由来のジアホラーゼ(製
品番号D3752)はシグマ社より購入した。Next, the present invention will be described specifically with reference to examples. Diaphorase I from Bacillus stearothermophilus used in the present invention (Product No. 100436),
II (product number 100377) and glucokinase (product number 120387) were purchased from Seikagaku Corporation. Diaphorase derived from Clostridium kluyberg (Product No. D5540) and diaphorase derived from pig heart (Product No. D3752) were purchased from Sigma.
【0037】ヘキソキナーゼ(製品番号142636
2)、グルコース6−リン酸デヒドロゲナーゼ(以下、
G6PDHと略す、製品番号737208)、クレアチ
ンキナーゼ(製品番号126969)はベーリンガー・
マンハイム社より購入した。それぞれの酵素活性は、購
入時の添付書又はラベルに記載してある値をそのまま用
いた。Hexokinase (product number 142636)
2), glucose 6-phosphate dehydrogenase (hereinafter, referred to as
G6PDH, product number 737208), creatine kinase (product number 126969) is available from Boehringer
Purchased from Mannheim. For each enzyme activity, the value described in the package insert or label at the time of purchase was used as it was.
【0038】テトラゾリウムブルー(以下、TBと略
す、製品番号1871−22−3)、ネオテトラゾリウ
ムブルー(以下、NeoTBと略す、製品番号298−
95−3)、MTT(製品番号2348−71−2)、
INT(製品番号146−68−9)、ニトロテトラゾ
リウムブルー(以下、NTBと略す、製品番号298−
83−9)、WST−1(製品番号150849−52
−8)は同仁化学研究所社より購入した。WST−8は
同仁化学研究所からサンプルとして入手した。ニトロブ
ルーテトラゾリウム(以下、NBTと略す、製品番号N
6876)、TV(製品番号T0174)、TR(製品
番号T84859)はシグマ・アルドリッチ社より購入
した。セルロース粉末(製品番号075−41)はナカ
ライテスク社より購入した。その他の試薬は市販の特級
を用いた。Tetrazolium blue (hereinafter abbreviated as TB, product number 1871-22-3), neotetrazolium blue (hereinafter abbreviated as NeoTB, product number 298-)
95-3), MTT (product number 2348-71-2),
INT (product number 146-68-9), nitrotetrazolium blue (hereinafter abbreviated as NTB, product number 298-)
83-9), WST-1 (product number 150849-52)
-8) was purchased from Dojindo Laboratories. WST-8 was obtained as a sample from Dojindo Laboratories. Nitro blue tetrazolium (hereinafter abbreviated as NBT, product number N
6876), TV (product number T0174), and TR (product number T84859) were purchased from Sigma-Aldrich. Cellulose powder (product number 075-41) was purchased from Nacalai Tesque. Other reagents used were commercially available special grades.
【0039】参考例1500mMのイミダゾール緩衝液
(pH6.7)に、最終濃度で50mMのWST−8と
クロストリジウム・クルイベリ由来のジアホラーゼ10
ユニット/mlとを含む溶液を調製し、この溶液をペリ
スタリックポンプを用いて5mm幅のポリウレタン製フ
ィルム上に約1cm間隔で1滴(約20μl)ずつ滴下
した。このフィルムを、約50℃の熱風乾燥ゾーンを通
過させて(通過時間約2分)乾燥した後、滴下した箇所
を中心として5×5mmの大きさに切断して試験片を得
た。この試験片を3×3mmの大きさの窓をあけた型枠
基板に両端で接着した。Reference Example 1 In a 500 mM imidazole buffer (pH 6.7), a final concentration of 50 mM WST-8 and diaphorase 10 derived from Clostridium kluyberg were used.
Unit / ml was prepared, and the solution was dropped on a 5 mm-wide polyurethane film at intervals of about 1 cm (about 20 μl) using a peristaltic pump. The film was dried by passing it through a hot air drying zone at about 50 ° C. (passing time: about 2 minutes), and then cut into a size of 5 × 5 mm around the point of dropping to obtain a test piece. The test piece was bonded at both ends to a form substrate having a 3 × 3 mm window.
【0040】得られた試験片に所定の濃度のNADHを
含む水溶液2μlを滴下し、5分後に色彩色差計(ミノ
ルタ社製、CR−200)を用いて550nmの反射率
を測定した。その結果を図1に示す。図1はNADH濃
度と反射率の関係を示す図である。この図から、上記の
試験片を用いることにより、NADHを反射率から正確
に定量できることがわかる。また、この結果より、明細
書中に記載したような各種デヒドロゲナーゼを共存させ
た試験片を作製することで、任意の被測定物質の定量が
可能であることがわかる。2 μl of an aqueous solution containing a predetermined concentration of NADH was dropped on the obtained test piece, and after 5 minutes, the reflectance at 550 nm was measured using a colorimeter (CR-200, manufactured by Minolta). The result is shown in FIG. FIG. 1 is a diagram showing the relationship between NADH concentration and reflectance. From this figure, it can be seen that NADH can be accurately quantified from the reflectance by using the above test piece. From the results, it can be seen that any test substance can be quantified by preparing a test piece in which various dehydrogenases coexist as described in the specification.
【0041】実施例1 以下のようにしてクレアチンキナーゼ定量用試験片を作
製した。すなわち、100mMのイミダゾール酢酸緩衝
液(pH6.7)に、最終濃度で30mMのクレアチン
リン酸、50mMのグルコース、5mMのNAD、5m
MのADP、10mMの酢酸マグネシウム、2mMのE
DTA−2Na、25mMのNAC、4重量%のWST
−1を溶解した。この溶液約350μlに約30000
U/mlのブタ心臓由来のジアホラーゼ溶液2μlと1
650ユニット/mlのG6PDH10μl、3600
ユニット/mlのヘキソキナーゼ1μlを添加した。こ
の溶液をピペットマンを用いて、ポリエチレンテレフタ
レート膜上に滴下し、風乾後、ビニルピロリドン酢酸ビ
ニルコポリマー(重量比で20:80)の1容量%メタ
ノールを塗布し、速やかにセルロース粉末を50容量%
メタノールに懸濁し、小量塗布した。これを40〜50
℃で乾燥してポリエチレンテレフタレート支持膜の試験
片を得た。この試験片にクレアチンキナーゼの溶液を5
μl滴下し、30秒ごとに反射率を測定した。Example 1 A test piece for creatine kinase quantification was prepared as follows. That is, a final concentration of 30 mM creatine phosphate, 50 mM glucose, 5 mM NAD, 5 mM in 100 mM imidazole acetate buffer (pH 6.7).
M ADP, 10 mM magnesium acetate, 2 mM E
DTA-2Na, 25 mM NAC, 4 wt% WST
-1 was dissolved. About 30000 in about 350 μl of this solution
2 μl of diaphorase solution from U / ml porcine heart and 1
10 μl of G6PDH at 650 units / ml, 3600
1 μl of unit / ml hexokinase was added. This solution was dropped on a polyethylene terephthalate film using a pipetteman, air-dried, and then 1% by volume of methanol of vinylpyrrolidone vinyl acetate copolymer (20:80 in weight ratio) was applied.
It was suspended in methanol and applied in a small amount. This is 40-50
After drying at ℃, a test piece of a polyethylene terephthalate support membrane was obtained. A creatine kinase solution was added to the test piece for 5 minutes.
μl was dropped, and the reflectance was measured every 30 seconds.
【0042】WST−8に代えてWST−1を用いた以
外は参考例1と同様にしてNADH濃度と反射率の関係
を示す検量線を作成し、この検量線を用いて、反射率よ
り、単位時間当りのNADHに相当する変化量を計算し
た。その結果を図2に示す。図2は、クレアチンキナー
ゼの活性測定の結果を示す図であり、縦軸にNADHに
相当する変化量を、横軸にクレアチンキナーゼ活性を示
している。この図から、本発明の試験片を用いることに
より少なくとも3000ユニット/lのクレアチンキナ
ーゼの定量が可能であることがわかる。A calibration curve showing the relationship between NADH concentration and reflectance was prepared in the same manner as in Reference Example 1 except that WST-1 was used in place of WST-8. The amount of change corresponding to NADH per unit time was calculated. The result is shown in FIG. FIG. 2 is a diagram showing the results of creatine kinase activity measurement, in which the vertical axis indicates the amount of change corresponding to NADH, and the horizontal axis indicates creatine kinase activity. From this figure, it can be seen that quantification of creatine kinase of at least 3000 units / l is possible by using the test piece of the present invention.
【0043】実施例2 以下のようにしてクレアチンキナーゼ定量用試験片を作
製した。すなわち、100mMのイミダゾール酢酸緩衝
液(pH6.7)に、最終濃度で30mMのクレアチン
リン酸、50mMのグルコース、20mMのNAD、1
0mMのADP、10mMの酢酸マグネシウム、2mM
のEDTA−2Na、25mMのNAC、5重量%のT
Rを溶解した。この溶液約350μlに約30000ユ
ニット/mlのバチルス・ステアロサーモフィルス由来
のジアホラーゼI溶液2μlと1650ユニット/ml
のG6PDH10μl、2500ユニット/mlのグル
コキナーゼ2μlを添加した。この溶液をアドバンテッ
ク社製のポリフロン濾紙(PF050)の3×3mmの
小片にピペットマンを用いて2μl滴下し、凍結乾燥し
て試験片を得た。この試験片を台紙に両面テープで張り
つけた。この試験片にクレアチンキナーゼの溶液を5μ
l滴下し、15秒毎に反射率を測定した。Example 2 A test piece for creatine kinase quantification was prepared as follows. That is, a final concentration of 30 mM creatine phosphate, 50 mM glucose, 20 mM NAD, 100 mM imidazole acetate buffer (pH 6.7) was added to 100 mM imidazole acetate buffer (pH 6.7).
0 mM ADP, 10 mM magnesium acetate, 2 mM
EDTA-2Na, 25 mM NAC, 5 wt% T
R was dissolved. To about 350 μl of this solution, 2 μl of a bacterium stearothermophilus-derived diaphorase I solution of about 30,000 units / ml and 1650 units / ml
Of G6PDH, 2 μl of glucokinase at 2500 units / ml. 2 μl of this solution was dropped on a 3 × 3 mm small piece of polyflon filter paper (PF050) manufactured by Advantech Co. using a pipetman, and freeze-dried to obtain a test piece. The test piece was stuck to the backing with a double-sided tape. 5 μl of a creatine kinase solution was added to the test piece.
1 drop, and the reflectance was measured every 15 seconds.
【0044】WST−8に代えてTRを用いた以外は参
考例1と同様にしてNADH濃度と反射率の関係を示す
検量線を作成し、この検量線を用いて、反射率より、単
位時間当りのNADHに相当する変化量を計算した。ま
た、この試験片(クレアチンキナーゼの希釈液を滴下す
る前のもの)にアルミホイルを巻いて、37℃のドライ
オーブン中に1か月間放置した後、同様にしてクレアチ
ンキナーゼの濃度と、単位時間当たりのNADHに相当
する変化量の関係を調べた。その結果を図3に示す。図
3は、作製直後及び1か月放置後の試験片を用いてクレ
アチンキナーゼの活性を測定した結果を示す図であり、
図3中の●は、作製後すぐにクレアチンキナーゼを滴下
したときの結果を、○は1か月間放置した後に測定した
ときの結果を示している。図3から、本発明の試験片を
用いることにより少なくとも3000ユニット/lのク
レアチンキナーゼの定量が可能であることがわかる。ま
た、本発明の試験片は保存安定性に優れていることがわ
かる。A calibration curve showing the relationship between NADH concentration and reflectance was prepared in the same manner as in Reference Example 1 except that TR was used in place of WST-8. The amount of change corresponding to NADH per hit was calculated. The test piece (before the creatine kinase diluent was dropped) was wrapped with aluminum foil and allowed to stand in a 37 ° C. dry oven for one month. Similarly, the creatine kinase concentration and the unit time were measured. The relationship of the amount of change corresponding to NADH per unit was examined. The result is shown in FIG. FIG. 3 is a diagram showing the results of measuring the activity of creatine kinase using test pieces immediately after preparation and after standing for one month,
3 in FIG. 3 shows the result when creatine kinase was dropped immediately after the preparation, and ○ shows the result when measured after standing for one month. FIG. 3 shows that the use of the test strip of the present invention enables quantification of creatine kinase of at least 3000 units / l. Further, it can be seen that the test piece of the present invention has excellent storage stability.
【0045】参考例2〜5、比較例1〜6 100mMのイミダゾール緩衝液(pH6.7)に、最
終濃度で30mMの表1に示す各テトラゾリウムとバチ
ルス・ステアロサーモフィルス由来のジアホラーゼII1
0ユニット/mlを含む溶液を調製し、これを直径6m
mのワットマン社製のろ紙(No.2)に3μl滴下
し、乾燥させて試験片を作製した。この試験片に、5m
MのNADH溶液に浸した直径8mmのペーパーディス
ク(アドバンテック社製、製品番号49005010)
を水平にすばやく接触させ、およそ1分後の試験片の発
色の状態を目視により観察した。その結果を表1に示
す。Reference Examples 2 to 5 and Comparative Examples 1 to 6 A 100 mM imidazole buffer (pH 6.7) was added to a final concentration of 30 mM each of the tetrazolium shown in Table 1 and diaphorase II1 derived from Bacillus stearothermophilus.
A solution containing 0 units / ml was prepared and was
Then, 3 μl of the solution was dropped onto a Whatman filter paper (No. 2) and dried to prepare a test piece. 5 m
8 mm diameter paper disk immersed in NADH solution of M (product number 49005010, manufactured by Advantech)
Was quickly and horizontally contacted, and the color development of the test piece was visually observed after about 1 minute. Table 1 shows the results.
【0046】[0046]
【表1】 [Table 1]
【0047】表1から明らかなように、水溶性テトラゾ
リウムであるWST−1、WST−8、TR、TVを用
いた場合には、色素が試験片に均一に固定化されている
ことがわかる。また、試験片の作製の容易さの点では、
参考例の試験片の方が比較例の試験片より容易であっ
た。As is clear from Table 1, when WST-1, WST-8, TR, and TV, which are water-soluble tetrazolium, were used, the dye was uniformly fixed on the test piece. In addition, in terms of ease of preparation of test pieces,
The test piece of the reference example was easier than the test piece of the comparative example.
【0048】実施例3 以下のようにしてクレアチンキナーゼ定量用試験片を作
製した。すなわち、150mMのイミダゾール酢酸緩衝
液(pH6.6)に、最終濃度で25mMのクレアチン
リン酸、25mMのグルコース、2mMのNADP、2
mMのADP、5mMの酢酸マグネシウム、2mMのE
DTA−2K、30mMのNAC、12重量%のツイン
20、1重量%のWST−1を溶解した。この溶液約3
50μlにバチルス・ステアロサーモフィルス由来のジ
アホラーゼI溶液、G6PDH、グルコキナーゼを、最
終濃度がそれぞれ約500ユニット/ml、10ユニッ
ト/ml、10ユニット/mlとなるように添加した。
この溶液を直径6mmのアドバンテック社製の酢酸セル
ロース膜(製品番号A045A090C)にピペットマ
ンを用いて2μl滴下し、凍結乾燥させて試験片を作製
した。この試験片に、約3000ユニット/lのクレア
チンキナーゼの溶液に浸した直径8mmのペーパーディ
スク(アドバンテック社製、製品番号4900501
0)を水平にすばやく接触させ、以下のごとく経時的に
反射率を測定し、クレアチンキナーゼの活性値を測定し
た。Example 3 A test piece for creatine kinase quantification was prepared as follows. That is, a final concentration of 25 mM creatine phosphate, 25 mM glucose, 2 mM NADP, 150 mM imidazole acetate buffer (pH 6.6)
mM ADP, 5 mM magnesium acetate, 2 mM E
DTA-2K, 30 mM NAC, 12% by weight of Twin 20, and 1% by weight of WST-1 were dissolved. About 3 of this solution
Bacillus stearothermophilus-derived diaphorase I solution, G6PDH, and glucokinase were added to 50 μl so that the final concentrations would be about 500 units / ml, 10 units / ml, and 10 units / ml, respectively.
2 μl of this solution was dropped on a cellulose acetate membrane (product number A045A090C) manufactured by Advantech Co., Ltd. having a diameter of 6 mm using a pipetman, and freeze-dried to prepare a test piece. An 8 mm diameter paper disk (Advantech, product number 4900501) immersed in a creatine kinase solution of about 3000 units / l was placed on the test piece.
0) was quickly and horizontally contacted, and the reflectance was measured over time as described below, and the creatine kinase activity value was measured.
【0049】WST−8に代えてWST−1を用いた以
外は参考例1と同様にしてNADH濃度と反射率の関係
を示す検量線を作成し、この検量線を用いて、反射率よ
り、単位時間当りのNADHに相当する変化量の関係を
調べ、クレアチンキナーゼの活性値を計算した。測定は
4度行い、その再現性を確認した。測定の結果、クレア
チンキナーゼの活性値は3176±0ユニット/lであ
った。A calibration curve showing the relationship between NADH concentration and reflectance was prepared in the same manner as in Reference Example 1 except that WST-1 was used in place of WST-8. The relationship between the changes corresponding to NADH per unit time was examined, and the creatine kinase activity value was calculated. The measurement was performed four times, and the reproducibility was confirmed. As a result of the measurement, the activity value of creatine kinase was 3176 ± 0 units / l.
【0050】実施例4 WST−1に代えてWST−8を用いた以外は実施例3
と同様にしてクレアチンキナーゼの活性値を計算し、そ
の再現性を確認した。測定の結果、クレアチンキナーゼ
の活性値は2948±61ユニット/lであった。Example 4 Example 3 except that WST-8 was used instead of WST-1.
The creatine kinase activity value was calculated in the same manner as described above, and its reproducibility was confirmed. As a result of the measurement, the activity value of creatine kinase was 2948 ± 61 units / l.
【0051】実施例5 WST−1に代えてTRを用いた以外は実施例3と同様
にしてクレアチンキナーゼの活性値を計算し、その再現
性を確認した。測定の結果、クレアチンキナーゼの活性
値は2906±109ユニット/lであった。Example 5 The activity of creatine kinase was calculated in the same manner as in Example 3 except that TR was used in place of WST-1, and the reproducibility was confirmed. As a result of the measurement, the activity value of creatine kinase was 2906 ± 109 units / l.
【0052】実施例6 WST−1に代えてTVを用いた以外は実施例3と同様
にしてクレアチンキナーゼの活性値を計算し、その再現
性を確認した。測定の結果、クレアチンキナーゼの活性
値は2948±61ユニット/lであった。Example 6 The activity of creatine kinase was calculated in the same manner as in Example 3 except that TV was used in place of WST-1, and its reproducibility was confirmed. As a result of the measurement, the activity value of creatine kinase was 2948 ± 61 units / l.
【0053】比較例7 WST−1に代えてTBを用いた以外は実施例3と同様
にしてクレアチンキナーゼの活性値を計算し、その再現
性を確認した。その結果、試薬に沈殿が生じて試験片を
作製することができなかった。Comparative Example 7 The activity of creatine kinase was calculated in the same manner as in Example 3 except that TB was used in place of WST-1, and its reproducibility was confirmed. As a result, a precipitate was generated in the reagent, and a test piece could not be prepared.
【0054】比較例8 WST−1に代えてNeoTBを用いた以外は実施例3
と同様にしてクレアチンキナーゼの活性値を計算し、そ
の再現性を確認した。測定の結果、クレアチンキナーゼ
の活性値は1623±524ユニット/lであり、測定
値のバラツキが大きかった。また、試験片の発色の状態
を目視により観察すると、ムラになっていた。Comparative Example 8 Example 3 except that NeoTB was used instead of WST-1.
The creatine kinase activity value was calculated in the same manner as described above, and its reproducibility was confirmed. As a result of the measurement, the activity value of creatine kinase was 1623 ± 524 units / l, and the variation in the measured value was large. Further, when the state of color development of the test piece was visually observed, it was uneven.
【0055】比較例9 WST−1に代えてINTを用いた以外は実施例3と同
様にしてクレアチンキナーゼの活性値を計算し、その再
現性を確認した。測定の結果、クレアチンキナーゼの活
性値は1514±46ユニット/lであり、測定値のバ
ラツキが大きかった。また、試験片の発色の状態を目視
により観察すると、着色が非常に薄く、かつムラになっ
ていた。Comparative Example 9 The activity of creatine kinase was calculated in the same manner as in Example 3 except that INT was used in place of WST-1, and its reproducibility was confirmed. As a result of the measurement, the activity value of creatine kinase was 1514 ± 46 units / l, and the dispersion of the measured values was large. In addition, when the state of color development of the test piece was visually observed, the coloring was extremely thin and uneven.
【0056】比較例10 WST−1に代えてNTBを用いた以外は実施例3と同
様にしてクレアチンキナーゼの活性値を計算し、その再
現性を確認した。その結果、試薬に沈殿が生じて試験片
を作製することができなかった。Comparative Example 10 The activity of creatine kinase was calculated in the same manner as in Example 3 except that NTB was used in place of WST-1, and its reproducibility was confirmed. As a result, a precipitate was generated in the reagent, and a test piece could not be prepared.
【0057】比較例11 WST−1に代えてNBTを用いた以外は実施例3と同
様にしてクレアチンキナーゼの活性値を計算し、その再
現性を確認した。その結果、試薬に沈殿が生じて試験片
を作製することができなかった。Comparative Example 11 The activity of creatine kinase was calculated in the same manner as in Example 3 except that NBT was used in place of WST-1, and its reproducibility was confirmed. As a result, a precipitate was generated in the reagent, and a test piece could not be prepared.
【0058】比較例12 WST−1に代えてMTTを用いた以外は実施例3と同
様にしてクレアチンキナーゼの活性値を計算し、その再
現性を確認した。その結果、測定値のバラツキが非常に
大きく測定することができなかった。また、試験片の発
色の状態を目視により観察すると、ムラになっていた。Comparative Example 12 The activity of creatine kinase was calculated in the same manner as in Example 3 except that MTT was used in place of WST-1, and its reproducibility was confirmed. As a result, it was not possible to measure a measurement value with a very large variation. Further, when the state of color development of the test piece was visually observed, it was uneven.
【0059】実施例3〜実施例6、比較例7〜比較例1
2の結果より、水溶性テトラゾリウムを用いた本発明の
試験片ではクレアチンキナーゼの活性を測定することが
できたのに対して、他のテトラゾリウムを用いた場合で
は、試薬に沈殿が生じ、試験片を作製することができな
かったり、また、試験片を作製できても、反応が阻害さ
れるか、発色のムラが大きく、クレアチンキナーゼの活
性を測定することができないものであった。また、試験
片の作製の容易さの点では、本発明の試験片の方が比較
例の試験片より容易であった。Examples 3 to 6, Comparative Examples 7 to 1
From the results of 2, it was possible to measure the activity of creatine kinase in the test piece of the present invention using the water-soluble tetrazolium, whereas in the case of using another tetrazolium, a precipitate was formed in the reagent and the test piece was used. Was not able to be prepared, or even if a test piece could be prepared, the reaction was inhibited or the coloration was uneven and the activity of creatine kinase could not be measured. Further, the test piece of the present invention was easier than the test piece of the comparative example in terms of easiness of preparation of the test piece.
【0060】[0060]
【発明の効果】本発明の試験片は、広範囲の測定領域で
測定することができる。また、本発明の試験片は保存安
定性に優れている。The test piece of the present invention can be measured in a wide range of measurement. Further, the test piece of the present invention is excellent in storage stability.
【図1】テトラゾリウムとしてWST−8を添加した試
験片を用いてNADHの濃度を測定したときのNADH
濃度と反射率の関係を示す図である。FIG. 1 shows the NADH when the concentration of NADH was measured using a test piece to which WST-8 was added as tetrazolium.
It is a figure which shows the relationship between a density and a reflectance.
【図2】本発明の試験片を用いてクレアチンキナーゼの
活性を測定したときの結果を示す図である。FIG. 2 is a graph showing the results when the activity of creatine kinase was measured using the test strip of the present invention.
【図3】作製直後及び1か月放置後の試験片を用いてク
レアチンキナーゼの活性を測定したときの結果を示す図
である。FIG. 3 is a view showing the results when the activity of creatine kinase was measured using test pieces immediately after preparation and after standing for one month.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 近藤 仁司 京都府宇治市宇治小桜23番地 ユニチカ株 式会社中央研究所内 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Hitoshi Kondo 23 Uji Kozakura, Uji-city, Kyoto Prefecture Unitika's Central Research Laboratory
Claims (2)
ラーゼ、NAD又はNADP、水溶性テトラゾリウムを
含むことを特徴とする、クレアチンキナーゼ活性測定用
試験片。1. A test strip for measuring creatine kinase activity, comprising at least dehydrogenase, diaphorase, NAD or NADP, and water-soluble tetrazolium.
ドフェニル)−3−(4−ニトロフェニル)−5−
(2,4−ジスルホフェニル)−2H−テトラゾリウ
ム、2−(4−ニトロ,2−メトキシフェニル)−3−
(4−ニトロフェニル)−5−(2,4−ジスルホフェ
ニル)−2H−テトラゾリウム、2,3,5−トリフェ
ニル−2H−テトラゾリウム又は2,5−ジフェニル−
3−(1−ナフチル)−2H−テトラゾリウムである請
求項1記載の試験片。2. The method according to claim 1, wherein the water-soluble tetrazolium is 2- (4-iodophenyl) -3- (4-nitrophenyl) -5-.
(2,4-disulfophenyl) -2H-tetrazolium, 2- (4-nitro, 2-methoxyphenyl) -3-
(4-nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium, 2,3,5-triphenyl-2H-tetrazolium or 2,5-diphenyl-
The test piece according to claim 1, which is 3- (1-naphthyl) -2H-tetrazolium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35747898A JPH11253193A (en) | 1997-12-19 | 1998-12-16 | Test piece for assaying creatine kinase activity |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35051797 | 1997-12-19 | ||
JP9-350517 | 1997-12-19 | ||
JP35747898A JPH11253193A (en) | 1997-12-19 | 1998-12-16 | Test piece for assaying creatine kinase activity |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11253193A true JPH11253193A (en) | 1999-09-21 |
Family
ID=26579218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35747898A Pending JPH11253193A (en) | 1997-12-19 | 1998-12-16 | Test piece for assaying creatine kinase activity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11253193A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879567B2 (en) | 2004-10-05 | 2011-02-01 | Asahi Kasei Pharma Corporation | Method for stabilizing coenzyme and composition therefor |
JP2012183034A (en) * | 2011-03-07 | 2012-09-27 | Toyobo Co Ltd | Exothermic test specimen promoting enzyme reaction for biochemical analysis |
JP2013126410A (en) * | 2011-11-15 | 2013-06-27 | Eiken Chemical Co Ltd | Detection and measuring method for enzyme activity, and kit using the same |
JP2014143942A (en) * | 2013-01-29 | 2014-08-14 | Toyobo Co Ltd | Diaphorase composition |
-
1998
- 1998-12-16 JP JP35747898A patent/JPH11253193A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879567B2 (en) | 2004-10-05 | 2011-02-01 | Asahi Kasei Pharma Corporation | Method for stabilizing coenzyme and composition therefor |
US8026075B2 (en) | 2004-10-05 | 2011-09-27 | Asahi Kasei Pharma Corporation | Method for stabilizing coenzyme and composition thereof |
JP2012183034A (en) * | 2011-03-07 | 2012-09-27 | Toyobo Co Ltd | Exothermic test specimen promoting enzyme reaction for biochemical analysis |
JP2013126410A (en) * | 2011-11-15 | 2013-06-27 | Eiken Chemical Co Ltd | Detection and measuring method for enzyme activity, and kit using the same |
JP2014143942A (en) * | 2013-01-29 | 2014-08-14 | Toyobo Co Ltd | Diaphorase composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6586199B2 (en) | Stabilized tetrazolium reagent compositions and methods for using the same | |
US5912139A (en) | Test strip | |
RU2288273C2 (en) | Composition of reagents, reagent test-band, system, method and set for detecting or assay of analyte presence in physiological sample | |
US6939685B2 (en) | Stabilized tetrazolium phenazine reagent compositions and methods for using the same | |
US4781890A (en) | Multilayer chemical analytical element | |
US4361648A (en) | Color fixed chromogenic analytical element | |
EP0200540B1 (en) | Analytical element and method for determination of creatine kinase isoenzyme | |
JP2003528623A (en) | Reagent system for detecting the presence of reduced cofactor in a sample and methods of use thereof | |
US6130054A (en) | Test strip for creatine kinase activity measurement | |
US4803158A (en) | Composition used for the determination of beta-hydroxybutyric acid and a method for preparing the said composition | |
JPH11253193A (en) | Test piece for assaying creatine kinase activity | |
US5776779A (en) | Integral multi-layer element for analyzing bile acid sulfate | |
JPH01128797A (en) | Method for quantitative determination of compound | |
JPS6259782B2 (en) | ||
JPS60210998A (en) | Test composition, test kit and method for enzymatical measurement of inorganic phosphate | |
JPH0353896A (en) | Dry creatinine analytical element and use thereof | |
JPH0579319B2 (en) | ||
JPS6293662A (en) | Dry analytical element containing oxidizing type coenzyme | |
AU2001288935A2 (en) | Test-strips with positively charged membranes for tetrazolium based assays | |
JPS62272994A (en) | Production of test paper for measuring bile acid | |
DE10221846A1 (en) | Detecting an analyte by enzymatic reaction, useful specifically for measuring glucose in blood, based on reaction with coenzyme and inactive coenzyme-binding protein | |
JPS58150860A (en) | Analysis element |